抗发作药物与食品和饮料之间的相互作用:系统性审查
Ali A Asadi-Pooya1,2, Cecilie Johannessen Landmark3,4, Nafiseh Mirzaei Damabi1
1Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Epilepsia open
|February 12, 2024
概括
抗发作药物 (ASM) 与食物或饮料之间的相互作用是常见的,可以改变药物水平. 患者应考虑这些相互作用,因为它们可能需要调整剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 胃肠病学 胃肠病学
背景情况:
- 抗发作药物 (ASM) 是的主要治疗方法,通常需要长期使用.
- 了解药物与食物的相互作用对于优化ASM治疗和患者的治疗结果至关重要.
研究的目的:
- 系统地审查和综合有关ASM与食品/饮料之间的相互作用的信息.
- 为管理ASM患者的医疗保健专业人员提供实用见解.
主要方法:
- 在MEDLINE和ScienceDirect进行了系统的文献搜索,截至2023年7月15日.
- 关键词包括"食物或饮料"和"抗或抗发作药".
- 应用了包含和排除标准,确定了19项相关研究.
主要成果:
- 所有包括的研究都提供了低水平的证据.
- 药物与食品的相互作用与ASM是频繁的,并受到各种因素的影响.
- 相互作用可以改变ASM暴露和血水平,可能需要剂量修改 (例如,葡萄汁与卡巴马泽,脂肪食物与大麻).
结论:
- ASM与食品/饮料之间的相互作用是常见的,并且具有临床意义.
- 这些相互作用需要在患者咨询和治疗管理过程中仔细考虑.
- 需要进一步的精心设计的研究来阐明特定的食品-ASM相互作用及其临床重要性.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183
Antiepileptic Drugs: Sodium Channel Blockers
560
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
560
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
302
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
302
Antiepileptic Drugs: Glutamate Antagonists
357
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
357
Antiepileptic Drugs: Calcium Channel Blockers
401
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
401
Antiepileptic Drugs: GABAergic Pathway Potentiators
402
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
402


